Barbora Brodska

Prague, PR 12820, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

PD-L1 Expression in Acute Myeloid Leukemia Cells: Associations With Cell Metabolism.

PD-L1 Expression in Acute Myeloid Leukemia Cells: Associations With Cell Metabolism.

Journal: Journal of immunology research

Published: January 19, 2026

TGF-β Decreases NK Cell Mobility and Cytotoxic Efficacy in Complex in vitro Models of the Leukemia Microenvironment.

TGF-β Decreases NK Cell Mobility and Cytotoxic Efficacy in Complex in vitro Models of the Leukemia Microenvironment.

Journal: ImmunoTargets and therapy

Published: December 19, 2024

Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant.

Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant.

Journal: PloS one

Published: November 01, 2024

Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment.

Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: March 20, 2023

Two-photon lifetime-based photoconversion of EGFP for 3D-photostimulation in FLIM.

Two-photon lifetime-based photoconversion of EGFP for 3D-photostimulation in FLIM.

Journal: Methods and applications in fluorescence

Published: December 23, 2022

Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53.

Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53.

Journal: The FEBS journal

Published: October 27, 2022

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia.

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia.

Journal: Oncoimmunology

Published: May 13, 2022

AML-Related NPM Mutations Drive p53 Delocalization into the Cytoplasm with Possible Impact on p53-Dependent Stress Response.

AML-Related NPM Mutations Drive p53 Delocalization into the Cytoplasm with Possible Impact on p53-Dependent Stress Response.

Journal: Cancers

Published: April 27, 2021

Group I p21-activated kinases in leukemia cell adhesion to fibronectin.

Group I p21-activated kinases in leukemia cell adhesion to fibronectin.

Journal: Cell adhesion & migration

Published: January 19, 2021

Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinib.

Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinib.

Journal: International journal of oncology

Published: May 27, 2020

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization.

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization.

Journal: Scientific reports

Published: February 24, 2020

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations.

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations.

Journal: International journal of molecular sciences

Published: April 30, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026